DJIA 16,351.38 293.03 1.82%
NASDAQ 4,749.98 113.87 2.46%
S&P 500 1,948.86 35.01 1.83%
market minute promo

11.48 0.26 (2.32%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BCRX $11.48 2.32%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $11.31
Previous Close $11.22
Daily Range $11.03 - $11.48
52-Week Range $7.85 - $16.83
Market Cap $840.8M
P/E Ratio -26.71
Dividend (Yield) $0.00 (0.0%)
Volume 731,532
Average Daily Volume 1,017,945
Current FY EPS -$0.60

Sector

Healthcare

Industry

Drug Makers

BioCryst Pharmaceuticals, Inc. (BCRX) Description

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections. Website: http://www.biocryst.com/

News & Commentary

We Believe Healthcare's Next Biotech Buyout Target Is…

Which biotech company will be the next buyout target? To answer this question, we turned to three of our healthcare contributors, and this is what they had to say.

Investors' Radars Failed to Catch BioCryst Pharmaceuticals (BCRX), Has Yours?

Trade-Ideas: Biocryst Pharmaceuticals (BCRX) Is Today's Strong On High Relative Volume Stock

Market Has Not Yet Noticed Potential in BioCryst Pharmaceuticals (BCRX); Have You?

New Strong Buy Stocks for August 11th

Esperion Therapeutics (ESPR) Looks Good: Stock Up 16.3%

Premarket Biotech Digest: SeekingAlpha Biotech Idea, Gilead Sales Updates, Sanofi Diabetes Collabora

Premarket Biotech Digest: SeekingAlpha Biotech Idea, Gilead Sales Updates, Sanofi Diabetes Collaboration

2 Biotech Stocks That Could Skyrocket In The Next 12 Months

3 Stocks Pushing The Health Care Sector Lower

Why BioCryst Pharmaceuticals Was Sent to the Guillotine

BioCryst Pharmaceuticals crushes Wall Street's second-quarter expectations, but gets hammered anyway. Find out why.

See More BCRX News...

BCRX's Top Competitors

BCRX $11.48 (2.32%)
Current stock: BCRX
AMGN $152.29 (3.28%)
Current stock: AMGN
GILD $104.27 (2.74%)
Current stock: GILD
BIIB $304.21 (4.00%)
Current stock: BIIB